PIERAGNOLI, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 1.772
EU - Europa 663
AS - Asia 259
AF - Africa 1
SA - Sud America 1
Totale 2.696
Nazione #
US - Stati Uniti d'America 1.769
IE - Irlanda 164
PL - Polonia 146
IT - Italia 133
SE - Svezia 110
HK - Hong Kong 104
CN - Cina 63
RU - Federazione Russa 56
SG - Singapore 46
JO - Giordania 33
FI - Finlandia 25
DE - Germania 10
VN - Vietnam 8
UA - Ucraina 7
CA - Canada 3
GB - Regno Unito 3
BE - Belgio 2
FR - Francia 2
IN - India 2
NL - Olanda 2
PT - Portogallo 2
TR - Turchia 2
BR - Brasile 1
CH - Svizzera 1
JP - Giappone 1
MU - Mauritius 1
Totale 2.696
Città #
Fairfield 307
Ashburn 173
Dublin 164
Seattle 150
Warsaw 146
Woodbridge 146
Chandler 142
Cambridge 118
Houston 111
Wilmington 89
Hong Kong 70
Lawrence 52
Altamura 50
Ann Arbor 49
Princeton 37
Buffalo 35
Singapore 32
Beijing 29
Boston 27
Kent 22
Florence 21
San Diego 21
Jacksonville 18
Medford 18
Shanghai 13
Falls Church 10
New York 9
Norwalk 9
Boardman 7
Moscow 6
Milan 5
Campi Bisenzio 4
Dong Ket 4
West Jordan 4
Guangzhou 3
Los Angeles 3
Phoenix 3
Andover 2
Brussels 2
Capergnanica 2
Cesano Boscone 2
Cesena 2
Cosenza 2
London 2
Orenburg 2
Paris 2
Poggibonsi 2
Porto 2
Pune 2
Scarperia e San Piero 2
Terni 2
Trinitapoli 2
Washington 2
Anzio 1
Bern 1
Brescia 1
Helsinki 1
Izmir 1
Laurel 1
Leawood 1
Lecce 1
Marsicovetere 1
Massa E Cozzile 1
Montréal 1
Naples 1
Negrar 1
Philadelphia 1
Redwood City 1
Rome 1
Rui'an 1
Saga 1
Saint Paul 1
Samarate 1
Senago 1
Shenzhen 1
São Paulo 1
Toronto 1
Turin 1
Totale 2.164
Nome #
Hemodynamic sensor in cardiac implantable electric devices: the endocardial accelaration technology 139
Cardiac Resynchronization Therapy for End-Stage Hypertrophic Cardiomyopathy: The Need for Disease-Specific Criteria 110
Application of the Seattle Heart Failure Model in patients on cardiac resynchronization therapy. 104
Effects of smoking in patients treated with cardiac resynchronization therapy 97
Management of antithrombotic therapy in patients undergoing electrophysiological device surgery 93
Impact of cardiac resynchronization therapy on the severity of mitral regurgitation. 92
Sleep Disordered Breathing and Arrhythmia Burden in Pacemaker Recipients 91
Left ventricular mass and progenitor cells in chronic heart failure patients 88
A contribution for validation of ECG criteria for interatrial conduction delay. 85
Metabolomic does not predict response to cardiac resynchronization therapy in patients with heart failure 82
Effects of cryoablation and radiofrequency ablation on endothelial and blood clotting activation 80
Simplified Selvester Score: a practical electrocardiographic instrument to predict response to CRT 79
Implantable cardioverter defibrillator prevents sudden cardiac death in systemic sclerosis. 79
Dual-site left ventricular cardiac resynchronization therapy. 78
Larger interventricular conduction time enhances mechanical response to resynchronization therapy 77
Acute hemodynamic effect of left ventricular endocardial pacing in cardiac resynchronization therapy: assessment by pressure-volume loops. 77
Cardiac Resynchronization Therapy Acutely Improves Ventricular-Arterial Coupling by Reducing the Arterial Load: Assessment by Pressure-Volume Loops. 76
Cardiac memory in humans: vectocardiographic quantification in cardiac resynchronization therapy. 76
The influence of age on the psychological profile of patients with cardiac implantable electronic devices: results from the Italian population in a multicenter study conducted by the European Heart Rhythm Association 74
QRS duration in left bundle branch block does not affect left ventricular twisting in chronic systolic heart failure 73
CHADS2 and CHA2DS2-VASc scores to predict morbidity and mortality in heart failure patients candidates to cardiac resynchronization therapy 73
Acute effects of His bundle pacing versus left ventricular and right ventricular pacing on left ventricular function. 73
Multicenter experience with implantable defibrillators subject to recall. 72
Persistent atrial fibrillation in the elderly. A possible association with arterial stiffness, hyperuricemia and chronic inflammation 69
Atrial standstill disease progression documented after 13 years follow-up 68
Overweight and aging increase the risk of atrial fibrillation after cardiac surgery independently of left atrial size and left ventricular ejection fraction 65
Which factors predict the behavior of ventricular extrasystoles in athletes over time? 64
Effectiveness of subcutaneous implantable cardioverter-defibrillator testing in patients with hypertrophic cardiomyopathy 64
Autoantibodies against β1-Adrenergic Receptors: Response to Cardiac Resynchronization Therapy and Renal Function 61
Strength of clinical indication and therapeutic impact of the implantable cardioverter defibrillator in patients with hypertrophic cardiomyopathy 56
Patients' knowledge and attitudes regarding living with implantable electronic devices: Results of a multicentre, multinational patient survey conducted by the European Heart Rhythm Association 55
Long-term reduction of atrial tachyarrhythmia recurrences in patients paced for bradycardia-tachycardia syndrome. 51
Incidence of ventricular arrhythmias after biventricular defibrillator replacement: impact on safety of downgrading from CRT-D to CRT-P 47
Prevalence of Inherited Cardiac Diseases Among Young Patients Requiring Permanent Pacing 47
P3212 The effect of age on quality of life in patients with cardiac implantable electronic devices. The results of an EHRA Scientific Initiatives Committee multinational survey in Italian patients 28
Echo/Doppler-derived time intervals are able to predict left ventricular reverse remodeling after cardiac resynchronization therapy 24
Low incidence of arrhythmic syncope and pacemaker implantation in older patients with bifascicular block and implantable cardiac monitor 23
Resynchronization of mitral valve annular segments reduces functional mitral regurgitation in cardiac resynchronization therapy 20
Has mechanical dyssynchrony still a role in predicting cardiac resynchronization therapy response 20
Tricuspid annular plane systolic excursion evaluation improves selection of cardiac resynchronization therapy patients 15
Totale 2.745
Categoria #
all - tutte 9.700
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.700


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020588 0 25 9 53 78 77 80 84 73 50 46 13
2020/2021322 32 32 14 45 14 23 19 35 29 41 20 18
2021/2022279 9 13 21 7 11 17 17 17 19 11 61 76
2022/2023706 58 169 39 28 34 107 112 52 71 5 24 7
2023/2024332 6 35 42 15 28 55 18 85 5 11 26 6
2024/2025100 74 26 0 0 0 0 0 0 0 0 0 0
Totale 2.745